Literature DB >> 18785209

Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress.

Masato Tsuchiya1, Hiroshi Kono, Masanori Matsuda, Hideki Fujii, Ivan Rusyn.   

Abstract

Traditional herbal formulations, such as Juzen-taiho-to (TJ-48), are used extensively in medical practice in Asia even though their mechanism of action remains elusive. This study tested a hypothesis that TJ-48 is protective against hepatocarcinogenesis by impeding Kupffer cell-induced oxidative stress. Forty-eight patients were randomly assigned to receive TJ-48 (n = 10), or no supplementation (n = 38) for up to 6 years after surgical treatment for hepatocellular carcinoma (HCC). In addition, to investigate the mechanism of protective action of TJ-48, diethylnitrosamine-containing water was administered for 22 weeks to male mice that were fed regular chow or TJ-48-containing diet. Liver tumor incidence, cell proliferation, number of 8-hydroxy-2'-deoxyguanosine- or F4/80-positive cells, and cytokine expression were evaluated. Although most of the patients experienced recurrence of HCC, a significantly longer intrahepatic recurrence-free survival was observed in the TJ-48 group. In mice, TJ-48 inhibited the development of liver tumors, reduced oxidative DNA damage, inflammatory cell infiltration and cytokine expression. Administration of TJ-48 improves intrahepatic recurrence-free survival after surgical treatment of hepatocellular carcinoma. On the basis of animal experiments, we reason that the protective mechanism of TJ-48 involves inhibition of Kupffer cells. This leads to lower levels of pro-inflammatory cytokines and oxidants in liver which may slow down the process of hepatocarcinogenesis and improves hepatic recurrence-free survival in patients with HCC. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18785209      PMCID: PMC2571981          DOI: 10.1002/ijc.23828

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  45 in total

1.  Effects of Sho-Saiko-to on hepatocarcinogenesis and 8-hydroxy-2'-deoxyguanosine formation.

Authors:  Goshi Shiota; Yoshiko Maeta; Tomoyuki Mukoyama; Atsushi Yanagidani; Akihide Udagawa; Kenji Oyama; Kazuo Yashima; Yosuke Kishimoto; Yoichiro Nakai; Tetsuo Miura; Hisao Ito; Yoshikazu Murawaki; Hironaka Kawasaki
Journal:  Hepatology       Date:  2002-05       Impact factor: 17.425

2.  Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production.

Authors:  Masaaki Korenaga; Ting Wang; Yanchun Li; Lori A Showalter; Tehsheng Chan; Jiaren Sun; Steven A Weinman
Journal:  J Biol Chem       Date:  2005-09-08       Impact factor: 5.157

3.  Oxidative stress and hepatitis C viral infection.

Authors:  Kazuhiko Koike; Hideyuki Miyoshi
Journal:  Hepatol Res       Date:  2005-12-20       Impact factor: 4.288

4.  Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Akira Maki; Hiroshi Kono; Mayetri Gupta; Masami Asakawa; Tetsuya Suzuki; Masanori Matsuda; Hideki Fujii; Ivan Rusyn
Journal:  Ann Surg Oncol       Date:  2007-03       Impact factor: 5.344

5.  Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng.

Authors:  Y S Keum; K K Park; J M Lee; K S Chun; J H Park; S K Lee; H Kwon; Y J Surh
Journal:  Cancer Lett       Date:  2000-03-13       Impact factor: 8.679

6.  A Chinese traditional medicine, juzentaihoto, inhibits the O2- generation by macrophages.

Authors:  T Imamichi; K Hayashi; T Nakamura; K Kaneko; J Koyama
Journal:  J Pharmacobiodyn       Date:  1989-11

Review 7.  Use of herbal supplements for chronic liver disease.

Authors:  Cynthia Levy; Leonard D Seeff; Keith D Lindor
Journal:  Clin Gastroenterol Hepatol       Date:  2004-11       Impact factor: 11.382

Review 8.  A Kampo medicine "Juzen-taiho-to"--prevention of malignant progression and metastasis of tumor cells and the mechanism of action.

Authors:  I Saiki
Journal:  Biol Pharm Bull       Date:  2000-06       Impact factor: 2.233

9.  Association between reactive oxygen species and disease activity in chronic hepatitis C.

Authors:  N De Maria; A Colantoni; S Fagiuoli; G J Liu; B K Rogers; F Farinati; D H Van Thiel; R A Floyd
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

10.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

View more
  26 in total

Review 1.  Toxicological and pathophysiological roles of reactive oxygen and nitrogen species.

Authors:  Ruth A Roberts; Robert A Smith; Stephen Safe; Csaba Szabo; Ronald B Tjalkens; Fredika M Robertson
Journal:  Toxicology       Date:  2010-07-17       Impact factor: 4.221

2.  Juzentaihoto hot water extract alleviates muscle atrophy and improves motor function in streptozotocin-induced diabetic oxidative stress mice.

Authors:  Tomoaki Ishida; Michiro Iizuka; Yanglan Ou; Shumpei Morisawa; Ayumu Hirata; Yusuke Yagi; Kohei Jobu; Yasuyo Morita; Mitsuhiko Miyamura
Journal:  J Nat Med       Date:  2018-11-26       Impact factor: 2.343

3.  Cold-water extracts of Grifola frondosa and its purified active fraction inhibit hepatocellular carcinoma in vitro and in vivo.

Authors:  Chia-Hung Lin; Ching-Yao Chang; Kuan-Rong Lee; Hui-Ju Lin; Wu-Chou Lin; Ter-Hsin Chen; Lei Wan
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-24

4.  Chronic administration of ethanol leads to an increased incidence of hepatocellular adenoma by promoting H-ras-mutated cells.

Authors:  Emmanuelle Jeannot; Igor P Pogribny; Frederick A Beland; Ivan Rusyn
Journal:  Cancer Lett       Date:  2010-12-17       Impact factor: 8.679

5.  Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Authors:  Masao Omata; Laurentius A Lesmana; Ryosuke Tateishi; Pei-Jer Chen; Shi-Ming Lin; Haruhiko Yoshida; Masatoshi Kudo; Jeong Min Lee; Byung Ihn Choi; Ronnie T P Poon; Shuichiro Shiina; Ann Lii Cheng; Ji-Dong Jia; Shuntaro Obi; Kwang Hyub Han; Wasim Jafri; Pierce Chow; Seng Gee Lim; Yogesh K Chawla; Unggul Budihusodo; Rino A Gani; C Rinaldi Lesmana; Terawan Agus Putranto; Yun Fan Liaw; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2010-03-18       Impact factor: 6.047

6.  Cinnamomum cassia bark in two herbal formulas increases life span in Caenorhabditis elegans via insulin signaling and stress response pathways.

Authors:  Young-Beob Yu; Laura Dosanjh; Lixing Lao; Ming Tan; Bum Sang Shim; Yuan Luo
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

7.  Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma.

Authors:  Masato Tsuchiya; Joel S Parker; Hiroshi Kono; Masanori Matsuda; Hideki Fujii; Ivan Rusyn
Journal:  Mol Cancer       Date:  2010-04-09       Impact factor: 27.401

8.  Anti-inflammatory drugs reduce the risk of hepatocellular carcinoma development.

Authors:  Yasushi Rino; Kazuo Tarao
Journal:  ISRN Oncol       Date:  2011-07-07

9.  Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine.

Authors:  Shigeru Yutani; Nobukazu Komatsu; Satoko Matsueda; Munehiro Yoshitomi; Takahisa Shirahama; Akira Yamada; Kyogo Itoh; Tetsuro Sasada
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-10       Impact factor: 2.629

10.  First nationwide attitude survey of Japanese physicians on the use of traditional Japanese medicine (kampo) in cancer treatment.

Authors:  A Ito; K Munakata; Y Imazu; K Watanabe
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-22       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.